Long-term antibody response following COVID-19 vaccination in patients receiving peritoneal dialysis.
作者信息
Chinnadurai Rajkumar, Ramgobin Chittesh, Wu Henry H L, Hayes Emma, Collier Joanne, Lewis David, Poulikakos Dimitrios
机构信息
Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance Foundation Trust, Salford, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
出版信息
Semin Dial. 2022 Nov;35(6):559-560. doi: 10.1111/sdi.13079. Epub 2022 Mar 29.
Abstract
摘要
相似文献
1
Long-term antibody response following COVID-19 vaccination in patients receiving peritoneal dialysis.接受腹膜透析的患者接种新冠病毒疫苗后的长期抗体反应。
Semin Dial. 2022 Nov;35(6):559-560. doi: 10.1111/sdi.13079. Epub 2022 Mar 29.
2
Antibody response and safety of COVID-19 vaccine in peritoneal dialysis patients.新冠病毒疫苗在腹膜透析患者中的抗体反应及安全性
J Infect. 2022 Dec;85(6):e167-e171. doi: 10.1016/j.jinf.2022.10.014. Epub 2022 Oct 17.
3
Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.腹膜透析和血液透析患者对 SARS-CoV-2 mRNA 疫苗的长期抗体反应比较。
Nephrol Dial Transplant. 2022 Feb 25;37(3):602-604. doi: 10.1093/ndt/gfab321.
4
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort study.腹膜透析患者中新冠病毒疫苗接种的免疫原性和耐受性——一项前瞻性观察队列研究
Semin Dial. 2022 May;35(3):269-277. doi: 10.1111/sdi.13043. Epub 2021 Dec 1.
5
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。
Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.
6
Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines.使用信使核糖核酸疫苗对腹膜透析和血液透析患者进行新冠病毒疫苗接种后，体液免疫和细胞免疫反应相当，但副作用发生率不同。
Nephrol Dial Transplant. 2022 Mar 25;37(4):796-798. doi: 10.1093/ndt/gfab324.
7
COVID-19 Vaccination for Patients Undergoing Long-Term Hemodialysis.接受长期血液透析患者的新冠疫苗接种
Clin J Am Soc Nephrol. 2022 Jun;17(6):767-768. doi: 10.2215/CJN.04460422.
8
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.在阿拉伯联合酋长国，对接受透析治疗的患者接种国药控股 HB02 新冠疫苗后的抗体反应和临床后遗症进行分析。
Nephrology (Carlton). 2022 Mar;27(3):260-268. doi: 10.1111/nep.13980. Epub 2021 Oct 5.
9
Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.mRNA-1273 冠状病毒病 2019 疫苗接种在腹膜透析患者中的抗体反应和安全性 - 维也纳队列。
Front Immunol. 2021 Dec 2;12:780594. doi: 10.3389/fimmu.2021.780594. eCollection 2021.
10
COVID-19 vaccination in patients receiving dialysis.COVID-19 疫苗接种在接受透析治疗的患者中。
Nat Rev Nephrol. 2021 Dec;17(12):788-789. doi: 10.1038/s41581-021-00499-z. Epub 2021 Oct 11.
引用本文的文献
1
Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy-Experience from a Single Tertiary Centre.提高新冠疫苗接种率并减少接受肾脏替代治疗患者的健康不平等现象——来自一家三级中心的经验
Vaccines (Basel). 2022 Jun 13;10(6):939. doi: 10.3390/vaccines10060939.
Zotero 插件